RadNet, Inc.

RDNT

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Deerfield Management RTW Investments

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Deerfield ManagementNEWFeb 17, 2026

Shares: 49,951Value: $3.6M

**Signal Note: Deerfield Management Initiates RadNet Position** Deerfield's $3.6M entry into RDNT (diagnostic imaging network operator) signals conviction in outpatient imaging consolidation dynamics, likely driven by volume recovery post-pandemic and potential M&A optionality in a fragmented market. The position sizing suggests a tactical investment rather than core conviction, positioning for near-term operational improvements or acquisition interest from larger healthcare platforms.

RTW InvestmentsNEWFeb 17, 2026

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

NBIX2 funds IMCR2 funds LRMR2 funds SYRE2 funds SYK2 funds COGT2 funds GPCR2 funds CGEM

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief:

**RadNet Signal Note:** RTW Investments' $281M entry into RDNT (imaging services provider) appears driven by operational leverage potential in diagnostic imaging rather than a pipeline catalyst. The position size suggests conviction in RadNet's AI-enabled workflow optimization and margin expansion as utilization recovers post-COVID, though this is a services play without direct drug/indication exposure.